mitoxantrone has been researched along with Anemia, Hemolytic in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuga, T | 1 |
| Kohda, K | 1 |
| Hirayama, Y | 1 |
| Matsumoto, S | 1 |
| Nakazawa, O | 1 |
| Ando, M | 1 |
| Ezoe, A | 1 |
| Nobuoka, A | 1 |
| Mochizuki, C | 1 |
1 other study available for mitoxantrone and Anemia, Hemolytic
| Article | Year |
|---|---|
Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Infective Agents; Antineoplastic Combin | 1996 |